Chapter 14: Drugs Used for Parkinson’s Disease

Basic Pharmacology for Nurses 17th Ed by Clayton - Willihnganz

$2.99

Chapter 14: Drugs Used for Parkinson’s Disease

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

MULTIPLE CHOICE

 

  1. Which adverse effects associated with levodopa therapy would support the nursing diagnosis risk for injury?
a. Nausea and vomiting
b. Orthostatic hypotension
c. Anorexia and depression
d. Tachycardia and palpitations

 

 

ANS:  B

When initiating levodopa therapy, orthostatic hypotension may occur. Although generally mild, patients may experience dizziness and weakness. Symptoms usually resolve within 1 or 2 weeks once tolerance is developed to the levodopa therapy. Orthostatic hypotension increases the risk for injury in Parkinson’s patients because they are also experiencing alterations in gait patterns. Although nausea, vomiting, anorexia, and depression are adverse effects of levodopa, they do not contribute to a risk for falling. Tachycardia and palpitations are not common adverse effects of levodopa.

 

DIF:    Cognitive Level: Application           REF:   Page 208        OBJ:   6

TOP:   Nursing Process Step: Diagnosis

MSC:  NCLEX Client Needs Category: Safe, Effective Care Environment

NOT:  CONCEPT(S): Clinical Judgment; Patient Education; Safety

 

  1. Which vitamin will reduce the therapeutic effects of levodopa?
a. A
b. B6
c. C
d. D

 

 

ANS:  B

Pyridoxine (vitamin B6) will reduce the therapeutic effects of levodopa in oral doses of 5 to 10 mg or more. Generally, diets typically have less than 1 mg of vitamin B6 and therefore are not restricted. The ingredients in multivitamins, however, must be assessed. Vitamins A, C, and D do not affect therapy with levodopa.

 

DIF:    Cognitive Level: Comprehension     REF:   Page 208        OBJ:   6

TOP:   Nursing Process Step: Planning

MSC:  NCLEX Client Needs Category: Physiological Integrity

NOT:  CONCEPT(S): Clinical Judgment; Patient Education

 

  1. Which cholinergic symptoms of Parkinson’s disease are reduced with anticholinergic drugs?
a. Cognitive impairments
b. Rigidity
c. Tremors and drooling
d. Postural abnormalities

 

 

ANS:  C

Anticholinergic drugs will reduce the severity of tremors and drooling in patients with Parkinson’s disease. Anticholinergics are most useful when used in combination with levodopa. Anticholinergic drugs do not affect cognitive impairments. Anticholinergics have little effect on rigidity or on postural abnormalities.

 

DIF:    Cognitive Level: Knowledge            REF:   Page 215        OBJ:   7

TOP:   Nursing Process Step: Assessment

MSC:  NCLEX Client Needs Category: Physiological Integrity

NOT:  CONCEPT(S): Clinical Judgment; Patient Education

 

  1. What is the pharmacologic action of entacapone, a potent catechol O methyl transferase (COMT) inhibitor?
a. Slows the deterioration of dopaminergic nerve cells
b. Inhibits the relative excess of dopaminergic activity
c. Reduces the destruction of dopamine in peripheral tissues
d. Enhances the cholinergic symptoms of Parkinson’s disease

 

 

ANS:  C

Entacapone, a COMT inhibitor, reduces dopamine destruction in peripheral tissues. This significantly increases the amount of dopamine available to reach the brain. Entacapone, when used with carbidopa levodopa therapy, results in more constant dopaminergic stimulation. Entacapone is not effective when used alone. Entacapone does not affect the nerve cells but blocks enzymes that break down levodopa. Parkinson’s disease is characterized by a relative deficit of dopaminergic activity. Entacapone does not affect cholinergic symptoms of Parkinson’s disease.

 

DIF:    Cognitive Level: Knowledge            REF:   Page 202        OBJ:   5

TOP:   Nursing Process Step: Assessment

MSC:  NCLEX Client Needs Category: Physiological Integrity

NOT:  CONCEPT(S): Clinical Judgment; Patient Education

Additional information

Add Review

Your email address will not be published. Required fields are marked *